• Conditions and diseases

  • Blood and immune system •
  • Cancer •
  • Cardiovascular •
  • Central nervous system •
  • Digestive system •
  • Ear and nose •
  • Endocrine, nutritional and metabolic •
  • Eye •
  • Gynaecology, pregnancy and birth •
  • Infectious diseases •
  • Injuries, accidents and wounds •
  • Mental health and behavioural conditions •
  • Mouth and dental •
  • Musculoskeletal •
  • Respiratory •
  • Skin •
  • Urogenital

• Public health

  • Accidents and injuries •
  • Alcohol •
  • Behaviour change •
  • Cancer •
  • Cardiovascular disease •
  • Child health •
  • Child social care •
  • Chronic illness •
  • Diabetes •
  • Drugs •
  • Environmental health •
  • Infectious diseases •
  • Maternal health •
  • Mental health •
  • Non-communicable diseases •
  • Obesity and diet •
  • Occupational health •
  • Older people •
  • Physical activity •
  • Sexual health •
  • Smoking and tobacco •
  • Transport •
  • Vaccine preventable diseases •
  • Working with and involving communities

• Treatments, Procedures and Devices

  • Bones and joint surgery •
  • Cardiovascular surgery •
  • Cardiovascular system drug treatments •
  • Clinical devices •
  • Diagnostic imaging •
  • Diagnostic procedures •
  • Digestive tract and other abdominal organs surgery •
  • Drug treatments •
  • Endocrine system and breast surgery •
  • Eye surgery •
  • Nervous system surgery •
  • Radiotherapy •
  • Screening •
  • Surgical procedures •
  • Therapeutic procedures •
  • Tissue and organ donation •
  • Urogenital surgery

• Guidance by type

  • Clinical Guidelines •
  • Technology appraisals •
  • Public health guidance •
  • Diagnostics guidance •
  • Interventional procedures guidance •
  • Medical technologies guidance •
  • Cancer service guidance •
  • Quality standards

• Guidance by date

  • View the guidance by date published

About NICE guidance Close

Navigation

• NICE guidance

• Find guidance
• NICE Pathways
• Latest guidance
• Guidance by type
• Guidance in development
• How guidance is produced
• NICE guidance research recommendations
• Guidance for patients and public
• Other publications
• Patient safety solutions pilot
• Quality standards

Diabetes - type 1

Type 1 diabetes: diagnosis and management of type 1 diabetes in primary and secondary care

Status:	History
Publication date:	July 2004
Wave:	2
Process:	CG
Topic area: Endocrine, nutritional and metabolic

Project team | Schedule | Project history | Key documents

 

NICE project team

Centre for clinical practice lead:	Peter Littlejohns
Communications manager:	Phil Ranson
Guidelines commissioning manager:	Wendy Riches
Guidelines coordinator:	Bobbie Lloyd
Patient involvement lead:	Victoria Thomas (Adult) Jane Cowl (Childhood)
Lead collaborating centre:	The National Collaborating Centres for Chronic Conditions and Women's and Children's Health
Guidance developer contact:	Rob Grant (diabetes in adults) Martin Dougherty (diabetes in children)
Guidelines Development Group:	The Guideline Development Group (GDG) oversees the development process.

Top

Email enquiries

If you have any queries please email nice@nice.org.uk

Top

 

Provisional schedule

Scoping workshop:	08 October 2001
Consultation on draft scope with stakeholders:	22 August - 19 September 2001
Submission Date Text:	01 May 2002
Consultation on draft guideline with stakeholders:	6 - 31 October 2003
Consultation on final draft of guidance:	2 - 29 January 2004
Pre-publication check:	TBC
Publication date:	July 2004

Top

 

Project history

Date Update 19 February 2002   The remit for this guideline was received from the Department of Health and the National Assembly for Wales. Consultation on the draft scope is complete and the scope is being modified in the light of comments received. When completed it will be posted on the website. It will define what aspects of care the guideline will cover and to whom it will apply. See below for more information on the Institute's guideline development process. 10 April 2002 Scope added. 09 July 2002 Schedule and list of stakeholders amended. 27 September 2002 Development of the clinical guideline is under way and is being led by the National Collaborating Centre. The Guideline Development Group meets regularly to oversee and assist the identification, review and synthesis of the evidence, the incorporation of expert consensus opinion and the translation of the evidence into recommendations for practice and audit criteria. Three versions of the guideline are under preparation: a full guideline, a NICE short-form guideline and information for the public. 07 November 2003 Consultation on the first consultation draft of the guideline is complete and the guideline is being modified in the light of comments received. Please see timescales above for the dates of the final round of consultation with stakeholders. 30 January 2004 Consultation on the final consultation draft of the guideline is complete and the guideline is being modified in the light of comments received. 05 April 2004 Patient Involvement Leads added. 20 May 2004 Expected date of issue amended.

Top

 

Key documents

Diabetes - Type 1: stakeholder list 01 July 2011 Type 1 diabetes clinical guideline - second consultation 02 January 2004 Type 1 Diabetes Remit 09 April 2002 Scope Type 1 diabetes: diagnosis and management of type 1 diabetes in primary and secondary care 10 April 2002 Guideline Development Process - Information for Stakeholders 14 January 2002 Type 1 diabetes guideline - first consultation 06 October 2003 National Collaborating Centre for Women and Children's Health 02 June 2003

This page was last updated: 01 July 2011